Pterostilbene Blood Pressure Randomized Trial: What the Evidence Says

Pterostilbene Blood Pressure Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pa

3 min read · 572 wordsReviewed August 2026
A healthcare worker uses a sphygmomanometer to check a patient's blood pressure in a medical office. - Evidence evidence guide for pterostilbene blood pressure randomized trial
Photo by Thirdman on Pexels · Pexels License

Quick Answer

Pterostilbene Blood Pressure Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence aware guidance rather than medical advice.

Key Takeaways

  • 01This page is generated only from sources stored in the Migaku evidence knowledge base.
  • 02Current evidence mix: 1 randomized trial, 1 narrative review.
  • 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • 04This article is educational and does not replace care from a qualified clinician.

Pterostilbene Blood Pressure Randomized Trial: What the Evidence Says

Quick Answer

Pterostilbene Blood Pressure Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

  • This page is generated only from sources stored in the Migaku evidence knowledge base.
  • Current evidence mix: 1 randomized trial, 1 narrative review.
  • Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • This article is educational and does not replace care from a qualified clinician.

Evidence Map

Source Evidence type Level Date Identifier
Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trial randomized trial 2 2026-05-13 10.3389/fragi.2026.1773667
Blueberries and Honeysuckle Berries: Anthocyanin-Rich Polyphenols for Vascular Endothelial Health and Cardiovascular Disease Prevention narrative review 3 2025-12-12 10.3390/nu17243888

What The Sources Report

  • The deficiency of E2 in post-menopausal women can lead to osteoporosis, increased risk of cardiovascular disease and increased risk of type 2 diabetes. [Holmes Holly E. (2026); evidence level 2]
  • Hot flashes are associated with discomfort, poor sleep, fatigue and a decreased quality of life. [Holmes Holly E. (2026); evidence level 2]
  • Prospective cohort studies and randomized controlled trials suggest that higher intakes of anthocyanin-rich foods are associated with improved vascular function, lower blood pressure, and reduced risk of coronary events and CVD. [Jurja Sanda (2025); evidence level 3]
  • Clinical trials in various populations, ranging from healthy individuals to those with metabolic syndrome or elevated cardiometabolic risk, have reported improvements in surrogate markers of vascular health-including flow-mediated dilation (FMD), blood pressure, arterial stiffness, and circulating biomarkers of endothelial activation-after blueberry intake. [Jurja Sanda (2025); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For pterostilbene blood pressure randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

  • Holmes Holly E. (2026). Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trial. DOI: 10.3389/fragi.2026.1773667. PMCID: PMC13213337. PMID: 42211736. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13213337/
  • Jurja Sanda (2025). Blueberries and Honeysuckle Berries: Anthocyanin-Rich Polyphenols for Vascular Endothelial Health and Cardiovascular Disease Prevention. DOI: 10.3390/nu17243888. PMCID: PMC12735439. PMID: 41470833. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12735439/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.

FAQ

Frequently Asked Questions

M

Medically reviewed

Last reviewed August 17, 2026 by Migaku Evidence Review

← All GuidesSupplement Reference →